Human Health Division (HHD) Products
Product List by Generic Name
Lactic Acid + Citric Acid + Potassium
Composition:
Feelfree Gel: Each gram gel contains Lactic Acid BP 18 mg, Citric Acid BP 10 mg & Potassium Bitartrate USP 4 mg.
Indication:
Feelfree is indicated for the prevention of pregnancy in female of reproductive potential for use as an on-demand method of contraception.
Dose & Administration:
Administer 5 g gel Feelfree vaginally by the applicator immediately before (or up to one hour before) each episode of vaginal intercourse. May use during any part of the menstrual cycle or as directed by the physicians.
Linagliptin + Metformin
Composition:
Diplin™ M 500 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 500 mg.
Indications:
Diplin™ M 500 is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as
an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when
treatment with both Linagliptin and Metformin is appropriate.
Dose & Administration:
The maximum recommended dose is Linagliptin 2.5 mg/Metformin Hydrochloride 1000 mg twice daily Or as directed by the physician.
Linagliptin
Composition:
Diplin™ 5 Tablet: Each film coated tablet contains Linagliptin INN 5 mg
Indication:
Diplin™ is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
Dose & Administration:
The recommended dose of Diplin™ is 5 mg once daily. No dosage adjustment is required for hepatic or kidney impaired patients. Or as directed by the physician.
Loteprednol Etabonate + Tobramycin
Composition
Loteba™ Sterile Eye Suspension: Each ml contains Loteprednol
Etabonate INN 5 mg and Tobramycin USP 3 mg.
Indications
Loteba™ is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. The use of a combination drug with an anti-infective component is indicated
where the risk of superficial ocular infection is high, where dangerous number of bacteria will be present in the eye.
Dosage and administration
Shake the bottle well before use Apply 1 to 2 drops of Loteba™ into the conjunctival sac of the affected eye (s) every 4 to 6 hours. During the initial 24 to 48 hours, the dosing may be increased, to every 1 to 2 hours. Frequency should be
decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely or as directed by the physician
Levofloxacin
Composition:
LevoquinTM Sterile Eye Drops:
Each ml contains Levofloxacin Hemihydrate USP equivalent Levofloxacin 5mg.
LevoquinTM TS
Sterile Eye Drops: Each ml contains Levofloxacin Hemihydrate USP equivalent
Levofloxacin 15 mg.
Indications:
LevoquinTM Sterile Eye Drops is indicated for the
treatment of bacterial conjunctivitis caused by susceptible strains of
gram-positive bacteria.
Dosage & Administration:
Levoquin TM TS Sterile Eye Drops:
Days 1 & 3: Instill 1 drop in the affected eye(s) every 30 minutes to 2 hours while awake per day.
Days 4 to completion: Instill 1 drop in the affected eye(s) every 1-4 hours while awake per day.
or as directed by the physician
Levamlodipine
Composition
L-Amlo 1.25 Tablet:Each tablet contains Levamlodipine Maleate INN equivalent to
Levamlodipine 1.25 mg.
L-Amlo 2.5 Tablet:Each tablet contains Levamlodipine Maleate INN equivalent to
Levamlodipine 2.5 mg.
L-Amlo 5 Tablet:Each tablet contains Levamlodipine Maleate INN equivalent to Levamlodipine
5 mg.
Indication
L-Amlo is a calcium channel blocker which is used alone or in combination with other
antihypertensive agents for the treatment of hypertension. Lowering blood pressure reduces the
risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
Dose & Administration
Adult recommended dose: 2.5 mg orally once daily with maximum dose 5 mg once daily. For small, fragile or elderly patients or patients with hepatic insufficiency, 1.25 mg once daily starting dose is recommended.
Paediatric starting dose: 1.25 mg to 2.5 mg once daily or as directed by the physicians
Luliconazole
Composition:
Lulider Cream: Each gram cream contains Luliconazole INN 10 mg.
Pharmacology:
Exact mechanism of action against dermatophytes is unknown, luliconazole
appears to inhibit ergosterol synthesis by inhibiting the enzyme lanosterol
demethylase. Inhibition of this enzyme's activity by azoles results in decreased
amounts of ergosterol, a constituent of fungal cell membranes and a
corresponding accumulation of lanosterol.
Indication:
Lulider Cream is indicated for the topical treatment of interdigital tinea pedis,
tinea cruris and tinea corporis, in patients 18 years of age and older.
Dose & Administration:
Tinea pedis: A thin layer of cream, 1% should be applied to the affected area and
approximately 1inch of the immediate surrounding area(s) once daily for two
weeks or as directed by the physician.
Tinea cruris or tinea corporis: A thin layer of cream, 1% should be applied to the
affected area and approximately 1inch of the immediate surrounding area(s)
once daily for one week or as directed by the physician.
Contraindication:
No information is available.
Warning and Precaution:
Side Effects:
The most common adverse reaction (<1%) is application site reactions.
Use in Pregnancy and Lactation:
Pregnancy Category C.
Use in Children and Adolescents:
The safety and effectiveness of Lulider Cream, 1% in pediatric patients have not been established. The number of pediatric patients > 12 years of age were too small to adequately assess safety and efficacy.
Drug Interaction:
No information is available.
Overdose:
Storage:
Store below 30 C., away from light and in a dry place. Keep out of the reach of children.
Packing:
Lulider Cream: Each Pack has a laminated tube containing 10 g cream and an insert.
Lulider Cream: Each Pack has a laminated tube containing 30 g cream and an insert.
